No Data Available
Gujarat Terce Laboratories Share Price
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | 12.10 |
| EPS - TTM(₹) | 2.85 |
| MCap(₹ Cr.) | 26.88 |
| MCap Rank | 161 |
| PB Ratio(x) | 2.80 |
| Div Yield(%) | - |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 59.78 |
| 52W Low(₹) | 29.00 |
| MCap/Sales | 0.51 |
| Beta(1 Month) | 0.42 |
| BV/Share(₹) | 12.49 |
Gujarat Terce share price insights
ROE Outperforming 5 Year Average
Company delivered ROE of 22.63% in year ending Mar 31, 2026 outperforming its 5 year avg. of 1.72%. (Source: Standalone Financials)Topline Contraction
Sales de-grew by 5.33%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 33.84% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Gujarat Terce Share Price Update
Gujarat Terce Laboratories Ltd. share price moved down by -1.40% from its previous close of Rs 34.99. Gujarat Terce Laboratories Ltd. stock last traded price is 34.50
Share Price Value Today/Current/Last 34.50 Previous Day 34.99
Found Insights useful?
Gujarat Terce Share Price Returns
| 1 Day | -1.4% |
| 1 Month | -5.43% |
| 3 Months | -8.1% |
| 1 Year | -39.31% |
| 3 Years | N.A. |
| 5 Years | 255.67% |
Gujarat Terce Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Financials
Quarterly Dec 2019 Sep 2019 Jun 2019 Sep 2018 Total Income 10.12 11.16 6.94 7.98 Total Income Growth (%) -9.31 60.92 -13.01 18.23 Total Expenses 9.72 9.37 8.11 7.78 Total Expenses Growth (%) 3.76 15.53 4.22 6.08 EBIT 0.41 1.80 -1.17 0.20 EBIT Growth (%) -77.42 - -695.22 - Profit after Tax (PAT) 0.37 1.69 -1.22 0.10 PAT Growth (%) -78.25 - -1,298.23 - EBIT Margin (%) 4.01 16.10 -16.86 2.46 Net Profit Margin (%) 3.64 15.18 -17.55 1.27 Basic EPS (₹) 0.50 0.23 0.00 0.01 InsightsTopline Contraction
Sales de-grew by 5.33%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 33.84% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
No Data Available
No Data Available
InsightsCash from Operations vs PAT
Operating cash flow of Rs 1.71 cr is 0.78 times compared to the reported net profit of Rs 2.2 cr. (Source: Standalone Financials)
No Data Available
InsightsROE Outperforming 5 Year Average
Company delivered ROE of 22.63% in year ending Mar 31, 2026 outperforming its 5 year avg. of 1.72%. (Source: Standalone Financials)
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
Gujarat Terce Top Searches
Corporate Actions
General Meeting
-
Jun 01, 2026
Board Meeting
Audited Results & A.G.M.
May 26, 2026
Board Meeting
Audited Results & A.G.M.
May 26, 2026
Announced on Meeting on May 26, 2026 May 29, 2026 Audited Results & A.G.M. May 26, 2026 May 27, 2026 Audited Results & A.G.M. Dec 29, 2025 Feb 04, 2026 Quarterly Results Nov 03, 2025 Nov 08, 2025 Quarterly Results Aug 04, 2025 Aug 11, 2025 Quarterly Results No Data Available
No Data Available
Announced on Ex-Date Jul 28, 2011 - Split: Old FV10.0| New FV:5.0 Announced on Ex-Date Jun 29, 2010 - Rights ratio: 2 share for every 3 held at a price of Rs 15.0 Announced on Meeting on Jun 01, 2026 Aug 21, 2026 - Jul 28, 2025 Aug 21, 2025 - Aug 09, 2024 Sep 17, 2024 - Jun 08, 2023 Aug 25, 2023 A.G.M. Jun 24, 2021 Sep 07, 2021 Book closure from Sep 1, 2021 to Sep 7, 2021
About Gujarat Terce
Gujarat Terce Laboratories Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 26.88 Crore) operating in Pharmaceuticals sector.
Industry
Key Indices Listed On
-
Address
122/2, Ravi Estate,Bileshwarpura,Gandhinagar District, Gujarat - 382729
Executive Leadership
Natwarbhai P Prajapati
ChairmanAalap Prajapat
Managing Director & CEOAmrutbhai P Prajapati
Whole Time DirectorChhayaben A Shah
Independent DirectorAuditors
FAQs about Gujarat Terce share
- 1. What's the Gujarat Terce share price today?As on 16 Jun, 2026, 03:50 PM IST Gujarat Terce share price is down by 1.40% basis the previous closing price of Rs 34.99. Gujarat Terce share price is Rs 34.50. Return Performance of Gujarat Terce Shares:
- 1 Week: Gujarat Terce share price moved down by 0.14%
- 2. What are the returns for Gujarat Terce share?Return Performance of Gujarat Terce Shares:
- 1 Week: Gujarat Terce share price moved down by 0.14%
- 3. What's the market capitalization of Gujarat Terce?Gujarat Terce share has a market capitalization of Rs 26.88 Cr. Within Pharmaceuticals sector, it's market cap rank is 161.
- 4. What is the PE & PB ratio of Gujarat Terce?The PE ratio of Gujarat Terce stands at 12.1, while the PB ratio is 2.76.
- 5. What is 52 week high/low of Gujarat Terce share price?52 Week high of Gujarat Terce share is Rs 59.78 while 52 week low is Rs 29.00
Top Gainers
As on 03:59 PM | 16 Jun 2026Top Losers
As on 04:01 PM | 16 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.